True Wealth Design’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1K Hold
28
﹤0.01% 1945
2026
Q1
$758 Sell
28
-1
-3% -$34 ﹤0.01% 1904
2025
Q4
$1.24K Buy
29
+1
+4% +$38 ﹤0.01% 1633
2025
Q3
$794 Hold
28
﹤0.01% 1833
2025
Q2
$525 Buy
+28
New +$531 ﹤0.01% 1723

Other funds holding RIGL

True Wealth Design's RIGL Position: Q2 2026 in Review

True Wealth Design held its Rigel Pharmaceuticals (RIGL) position steady in Q2 2026 at 28 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

True Wealth Design first reported a position in RIGL in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.24K in Q4 2025. 7 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • True Wealth Design held 28 shares of Rigel Pharmaceuticals worth $1.1K as of Q2 2026.
  • True Wealth Design left its Rigel Pharmaceuticals share count unchanged in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1945 holding.
  • True Wealth Design first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • True Wealth Design's Rigel Pharmaceuticals position peaked at $1.24K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.